- cafead Apr 12, 2019 at 10:22: AM
via Hookipa Pharma Inc., a biotech that’s using arenavirus-based platforms to develop treatments targeting infectious diseases and cancers, set terms for its initial public offering shares this week, saying it will offer 6.7 million shares priced at $14 to $16 each.
article source
article source